76 related articles for article (PubMed ID: 1289890)
1. [The validation of the adequacy of chemotherapy in bladder tuberculosis based on a study of bacteriostatic activity].
Dovlatian AA; Dzhenzhera NA
Probl Tuberk; 1992; (11-12):49-51. PubMed ID: 1289890
[TBL] [Abstract][Full Text] [Related]
2. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
Int J Pharm; 2004 May; 276(1-2):41-9. PubMed ID: 15113612
[TBL] [Abstract][Full Text] [Related]
3. Single dose kinetics of rifampicin and isoniazid in well-nourished and malnourished patients of tuberculosis.
Garg SK; Dhand R; Malik SK; Kalra S; Gupta PH; Jha VK; Shukla VK; Lal R
Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):417-20. PubMed ID: 3220617
[TBL] [Abstract][Full Text] [Related]
4. [Drug therapy of urogenital tuberculosis].
König K
Urologe; 1970 Jan; 9(1):44. PubMed ID: 5461516
[No Abstract] [Full Text] [Related]
5. [Blood bacteriostatic activity in patients with tuberculosis of the urogenital system undergoing different methods of administration of antibacterial drugs].
Gabinskiĭ BSh
Probl Tuberk; 1971; 49(2):80-2. PubMed ID: 5105489
[No Abstract] [Full Text] [Related]
6. [Urogenital tuberculosis. Apropos of 40 cases].
el Khader K; el Fassi J; Karmouni T; Tazi K; Ibnattya A; Hachimi M; Lakrissa A
Ann Urol (Paris); 1997; 31(6-7):339-43. PubMed ID: 9509233
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetic factors and bioavailability of rifampicin, isoniazid and pyrazinamid fixed in one dose capsule.
Zwolska Z; Augustynowicz-Kopeć E; Niemirowska-Mikulska H
Acta Pol Pharm; 2002; 59(6):448-52. PubMed ID: 12669769
[TBL] [Abstract][Full Text] [Related]
8. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
[TBL] [Abstract][Full Text] [Related]
9. [Results of examination in healthy volunteers of rifampicin and isoniazid bioavailability from Polish two-drug combination capsules of rifamazid used for tuberculosis treatment].
Zofia Z; Niemirowska-Mikulska H; Augustynowicz-Kopeć E; Stambrowska A
Pneumonol Alergol Pol; 1998; 66(3-4):198-206. PubMed ID: 9857665
[TBL] [Abstract][Full Text] [Related]
10. [Urinary excretion of rifampicin in kidney failure when administered alone or together with isoniazid].
Titarenko OT; Vakhmistrova TI; Perova TL
Antibiotiki; 1983 Sep; 28(9):698-702. PubMed ID: 6638984
[TBL] [Abstract][Full Text] [Related]
11. [A severe form of urinary tuberculosis in children].
Erreimi N; Hida M; Mouane N; Bouchta F
Ann Urol (Paris); 1997; 31(4):177-80. PubMed ID: 9412338
[TBL] [Abstract][Full Text] [Related]
12. [Results of short-term tuberculosis therapy with isoniazid, rifampicin and pyrazinamide].
Brändli O; Dreher D; Morger D
Schweiz Med Wochenschr; 1993 Jun; 123(25):1300-6. PubMed ID: 8341998
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of isoniazid in pulmonary tuberculosis--a comparative study at two dose levels.
Roy V; Tekur U; Chopra K
Indian Pediatr; 1996 Apr; 33(4):287-91. PubMed ID: 8772902
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetic aspects of tuberculosis therapy with a fixed combination of rifampicin, isoniazide and pyrazinamide].
Schaberg T; Lode H
Z Gesamte Inn Med; 1991 Jun; 46(8):276-9. PubMed ID: 1897286
[TBL] [Abstract][Full Text] [Related]
15. Comparative bioequivalence study of rifampicin and isoniazid combinations in healthy volunteers.
Padgaonkar KA; Revankar SN; Bhatt AD; Vaz JA; Desai ND; D'Sa S; Shah V; Gandewar K
Int J Tuberc Lung Dis; 1999 Jul; 3(7):627-31. PubMed ID: 10423226
[TBL] [Abstract][Full Text] [Related]
16. [Tisamide in the complex treatment of tuberculosis].
Onishchenko VV; Sokolova GB; Koriakin VA; Shapatava MN; Iurchenko LN
Probl Tuberk; 1990; (7):43-5. PubMed ID: 2235951
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of specific blood activity in patients with fibrous-cavernous pulmonary tuberculosis during administration of different combinations of antibacterial preparations].
Mkrtchian SV; Utkin VV; Egorkina ND
Antibiotiki; 1970 Oct; 15(10):955-7. PubMed ID: 5487860
[No Abstract] [Full Text] [Related]
18. Rationale and experimental data in support of the use of a fixed-triple combination of isoniazid, rifampicin and pyrazinamide in the chemotherapy of tuberculosis.
Acocella G
G Ital Chemioter; 1987; 34(1-3):3-5. PubMed ID: 3504412
[No Abstract] [Full Text] [Related]
19. [Rifampicin in the treatment of urogenital tuberculosis. Apropos of the 1st 100 cases in man treated in a sanatorium].
Kalachnikoff P; Lengrand J; Herreros V
Ann Urol (Paris); 1972 May; 6(2):113-8. PubMed ID: 5053197
[No Abstract] [Full Text] [Related]
20. The effect of pyrazinamide and rifampicin on isoniazid metabolism in rats.
De Rosa HJ; Baldan HM; Brunetti IL; Ximenes VF; Machado RG
Biopharm Drug Dispos; 2007 Sep; 28(6):291-6. PubMed ID: 17571294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
